CD4+ T-cell receptor (TCR) recognizing tetanus toxoid-derived peptides (TT-specific TCR)

CD4+ T-cell receptors (TCRs) recognizing tetanus toxoid-derived peptides are specialized surface proteins on helper T lymphocytes that identify processed fragments of the tetanus toxin (PubMed: 15507524). These fragments are presented by Major Histocompatibility Complex (MHC) class II molecules, such as HLA-DR, on the surface of antigen-presenting cells (Journal of Immunology: 161(11)). These receptors play a critical role in the adaptive immune response by initiating the activation of CD4+ T cells upon exposure to the tetanus vaccine or the Clostridium tetani bacterium (StatPearls: Tetanus). Because most humans have been immunized against tetanus, these TCRs are frequently utilized in clinical research as a model for robust T-cell memory and as helper components in advanced immunotherapies to enhance responses against tumors (Nature Communications: 12, 564). The interaction between the TCR and the peptide-MHC complex triggers a signaling cascade that results in cytokine secretion, such as interferon-gamma and interleukin-2, which are essential for providing B-cell help and coordinating a comprehensive immune defense (PubMed: 25227774). In the context of drug development, these TCRs are the primary targets for tetanus vaccines and are being explored in the design of multi-specific immune engagers and TCR-engineered cell therapies (Frontiers in Immunology: 11, 585).

Other names

Tetanus toxoid-specific T-cell receptorTT-specific CD4+ TCRTetanus-specific TCRAnti-tetanus toxoid TCR

Recognition of tetanus toxoid peptides presented by MHC class II molecules on antigen-presenting cells, leading to T-cell activation, proliferation, and the secretion of cytokines to coordinate the immune response.